1. ScholarBank@NUS

Wei Peng Yong

rp05452

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
Main Affiliation
 
Faculty
 
Email
csiywp@nus.edu.sg
 

Publications

Refined By:
Department:  PATHOLOGY
Date Issued:  [2010 TO 2019]
Policy:  Open

Results 1-10 of 10 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
12018Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressorSubhash, V.V; Yeo, M.S; Wang, L ; Tan, S.H; Wong, F.Y; Thuya, W.L ; Tan, W.L; Peethala, P.C ; Soe, M.Y; Tan, D.S.P; Padmanabhan, N ; Baloglu, E; Shacham, S; Tan, P ; Koeffler, H.P ; Yong, W.P 
22016CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancerRoy R.K. ; Hoppe M.M. ; Srivastava S. ; Samanta A. ; Sharma N.; Tan K.T. ; Yang H.; Voon D.C. ; Pang B. ; Teh M. ; Murata-Kamiya N.; Hatakeyama M.; Chang Y.-T. ; Yong W.P. ; Ito Y. ; Ho K.Y. ; Tan P. ; Soong R. ; Koeffler P.H.; Yeoh K.G. ; Jeyasekharan A.D. 
321-May-2010Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular featuresAng, P.W.; Loh, M. ; Liem, N.; Lim, P.L.; Grieu, F.; Vaithilingam, A.; Platell, C.; Yong, W.P. ; Iacopetta, B.; Soong, R. 
42019FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling PathwayYeo; Subhash; KAZUTO SUDA ; HAYRI EMRAH BALCIOGLU ; ZHOU SIQIN ; THUYA WIN LWIN ; LOH XIN YI ; Jammula; PRAVEEN CHAKRAVARTHY PEETHALA ; Tan; Xie; Wong; Ladoux,Benoit ; Ito; YANG HE ; Goh; Wang; YONG WEI PENG 
53-May-2016Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinomaHuang, Baohua ; DENG SHUO ; LOO SER YUE ; ARPITA DATTA ; YAP YAN LIN ; Yan, Benedict; OOI CHIA HUEY ; DINH THUY DUONG ; ZHUO JINGLI ; LALCHHANDAMI TOCHHAWNG ; SUMA GOPINADHAN ; Jegadeesan, Tamilarasi; TAN BOON OOI,PATRICK ; SALTO-TELLEZ,MANUEL ; YONG WEI PENG ; SOONG CHUAN TECK,RICHIE ; YEOH KHAY GUAN ; GOH YAW CHONG ; PETER EDWARD LOBIE ; YANG HE ; ALAN PREM KUMAR ; Maciver, Sutherland K; SO BOK YAN,JIMMY ; Yap Suen Mei,Celestial Therese 
61-Jul-2016High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547Lau, Wen Min ; Teng, Eileen ; Huang, Kie Kyon ; Tan, Jin Wei ; Teh, Ming ; Yong, Wei Peng ; Sommer, Anette; Schatz, Christoph A; Tan, Patrick ; Chan, Shing Leng ; So, Jimmy 
72016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
82014SPHK1 regulates proliferation and survival responses in triplenegative breast cancerDatta, A ; Loo, S.Y ; Huang, B ; Wong, L ; Tan, S.S.L ; Tan, T.Z ; Lee, S.-C ; Thiery, J.P ; Lim, Y.C ; Yong, W.P ; Lam, Y ; Kumar, A.P ; Yap, C.T 
92015Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenibWong A.L.A. ; Lim J.S.J. ; Sinha A. ; Gopinathan A. ; Lim R.; Tan C.-S. ; Soh T.; Venkatesh S.; Titin C.; Sapari N.S. ; Lee S.-C. ; Yong W.-P. ; Tan D.S.P. ; Pang B. ; Wang T.-T. ; Zee Y.-K.; Soong R. ; Trnkova Z.; Lathia C.; Thiery J.-P.; Wilhelm S.; Jeffers M.; Goh B.-C. 
102018Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyHeong V.; Syn N.L.; Lee X.W.; Sapari N.S. ; Koh X.Q.; Adam Isa Z.F. ; Sy Lim J.; Lim D. ; Pang B. ; Thian Y.L. ; Ng L.K. ; Wong A.L. ; Soo R.A. ; Yong W.P. ; Chee C.E. ; Lee S.-C., Goh B.-C. ; Soong R. ; Tan D.S.P.